Big Move For Predictive Oncology Inc.

Predictive Oncology Inc. (POAI:NASDAQ) jumped higher at $1.07, representing a gain of 26%. On Mon, May 17, 2021, POAI:NASDAQ hit a New 2-Week Intraday Low of $0.81. The stock appeared on our News Catalysts scanner on Wed, May 12, 2021 at 05:55 PM in the 'INVESTOR UPDATE' category. From Mon, May 03, 2021, the stock recorded 10.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Feb 17, 2021 at $2.3 with a volume of 19M+, and its share price has been moving sideways in recent weeks.
About Predictive Oncology Inc. (POAI:NASDAQ)
Precision Therapeutics Inc functions in the healthcare domain. It is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed of.
Top 10 Gainers:
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 75.04%
- Landcadia Holdings II, Inc. (LCA:NASDAQ), 64.56%
- BMTX (BMTX:NYSEMKT), 26.42%
- Predictive Oncology Inc. (POAI:NASDAQ), 26.03%
- Ultralife Corporation (ULBI:NASDAQ), 23.38%
- Medley LLC SR NT 26 (MDLX:NYSE), 22.18%
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 22.03%
- Moxian, Inc. (MOXC:NASDAQ), 21.02%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 21%
- Aemetis, Inc. (AMTX:NASDAQ), 20.94%